Cosmetics Adverse Event Report Validation Should Be CFSAN Priority - CTFA
This article was originally published in The Rose Sheet
Executive Summary
FDA's cosmetics adverse reaction reporting process should be revised over the next fiscal year to assuage concerns about the accuracy of the reported information, the Cosmetic, Toiletry and Fragrance Association maintains in comments to the agency Aug. 25.
You may also be interested in...
"Insufficient Data" Labeling "Framework" Should Be CFSAN Priority - CTFA
An FDA "framework" for implementing a policy on ingredient safety labeling should be developed before a preliminary guidance on implementation is issued, the Cosmetic, Toiletry and Fragrance Association urges in Sept. 17 comments to the agency.
"Insufficient Data" Labeling "Framework" Should Be CFSAN Priority - CTFA
An FDA "framework" for implementing a policy on ingredient safety labeling should be developed before a preliminary guidance on implementation is issued, the Cosmetic, Toiletry and Fragrance Association urges in Sept. 17 comments to the agency.
AHA "Sun Alert" Labeling Recommended In CTFA Citizen Petition
The Cosmetic, Toiletry and Fragrance Association recommends FDA propose a regulation requiring a "sun alert" labeling statement on cosmetics containing alpha hydroxy acids in a June 29 citizen petition.